Palvella Therapeutics (PVLA) Cash from Investing Activities Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -356.39% |
| Sep 30, 2024 | -49.02% |
| Jun 30, 2024 | -29.96% |
| Mar 31, 2024 | 29.86% |
| Dec 31, 2023 | 21.62% |
| Sep 30, 2023 | -15.29% |
| Jun 30, 2023 | 51.08% |
| Mar 31, 2023 | 28.00% |
| Dec 31, 2022 | 15.15% |
| Sep 30, 2022 | 83.71% |
| Jun 30, 2022 | -74.95% |
| Mar 31, 2022 | -148.46% |
| Dec 31, 2021 | -7.58% |
| Sep 30, 2021 | -12.06% |
| Jun 30, 2021 | -32.21% |
| Mar 31, 2021 | 16.24% |
| Dec 31, 2020 | 113.40% |
| Sep 30, 2020 | 149.21% |
| Jun 30, 2020 | 178.77% |
| Mar 31, 2020 | 64.88% |
| Sep 30, 2019 | 210.82% |
| Jun 30, 2019 | 382.12% |
| Mar 31, 2019 | -396.16% |